BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7924634)

  • 61. Hypothyroidism preceding hyperthyroidism in a patient with continuously positive thyroid stimulating antibody.
    Yamasaki H; Takeda K; Nakauchi Y; Suehiro T; Hashimoto K
    Intern Med; 1995 Apr; 34(4):247-50. PubMed ID: 7606091
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Anti-TSH receptor antibody(TRAb, TBII, TSAb)].
    Amino N; Fujiwara M
    Nihon Rinsho; 2010 Jul; 68 Suppl 7():305-8. PubMed ID: 20960786
    [No Abstract]   [Full Text] [Related]  

  • 63. Thyroid stimulating antibodies in sarcoidosis.
    Attali JR; Valensi P; Valeyre D; Sandre-Banon D; Sebaoun J; Battesti JP
    Pathol Biol (Paris); 1994 Jun; 42(6):581-6. PubMed ID: 7854858
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Relationship between thyroid stimulating hormone and thyroid stimulating immunoglobulin in Graves' hyperthyroidism.
    Woeber KA
    J Endocrinol Invest; 2011 Mar; 34(3):222-4. PubMed ID: 20855936
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Prognostic value of anti-TSH receptor antibodies in Basedow's disease treated with carbimazole].
    Duprey J; Izembart M; Vallée G; Goupil M
    Ann Med Interne (Paris); 1986; 137(7):555-8. PubMed ID: 3813296
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Minor hyperthyroidism with normal levels of thyroid-stimulating hormone receptor antibodies: a case report.
    Ushakov AV
    J Med Life; 2024 Feb; 17(2):236-238. PubMed ID: 38813368
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Comparison of the New, Rapid, and Fully Automated Kryptor TSH receptor Antibodies Assay (B.R.A.H.M.S.) with the Radioimmunological Assay (B.R.A.H.M.S.).
    Chauvet J; Leven C; Thuillier P; Capaldo C; Moineau MP; Plée-Gautier E; Carré JL; Padelli M
    Clin Lab; 2019 Nov; 65(11):. PubMed ID: 31710438
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Stimulatory TSH-Receptor Antibodies and Oxidative Stress in Graves Disease.
    Diana T; Daiber A; Oelze M; Neumann S; Olivo PD; Kanitz M; Stamm P; Kahaly GJ
    J Clin Endocrinol Metab; 2018 Oct; 103(10):3668-3677. PubMed ID: 30099546
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Clinical validity of intercellular adhesion molecule-1 (ICAM-1) and TSH receptor antibodies in sera from patients with Graves' disease.
    Massart C; Sonnet E; Gibassier J; Maugendre D; Genetet B
    Clin Chim Acta; 1997 Sep; 265(2):157-68. PubMed ID: 9385458
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Characteristics of the clinical picture, hormonal status and humoral immunity in older patients with diffuse toxic goiter].
    Natarov VV; Grinchenko TS; Afanas'eva NI; Pesotskaia PM; Nikolaeva VM
    Ter Arkh; 1988; 60(12):96-8. PubMed ID: 3247664
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Sensitivity of assays for TSH-receptor antibodies.
    Bitcon V; Donnelly J; Kiaei D
    J Endocrinol Invest; 2016 Oct; 39(10):1195-6. PubMed ID: 27531172
    [No Abstract]   [Full Text] [Related]  

  • 72. Relationships between plasma thyrotropin receptor antibodies and lipid or lipoprotein parameters in Graves' disease.
    Rieu M; Revue E; Bonete R; Nunez S
    Eur J Endocrinol; 1996 Jul; 135(1):77-81. PubMed ID: 8765977
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Thyrotrophin-binding inhibiting immunoglobulins (TBII) in subacute thyroiditis.
    Wägar G; Mäkinen T
    Acta Endocrinol Suppl (Copenh); 1983; 251():53-7. PubMed ID: 6132510
    [TBL] [Abstract][Full Text] [Related]  

  • 74. In vivo stimulation of thyroid hormone release by rabbit antibodies with thyroid stimulating activity raised against the mutated receptor peptide TSH-R-HIS17.
    Hirooka Y; Mitsuma T; Nogimori T; Ishizuki Y; Sakai J; Naruse M; Fukayama M
    Life Sci; 1993; 53(8):659-64. PubMed ID: 8102469
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The interaction of thyrotrophin binding inhibiting immunoglobulins with high and low affinity TSH receptors.
    Pekonen F; Mäkinen T
    Acta Endocrinol Suppl (Copenh); 1983; 251():33-7. PubMed ID: 6132509
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Soluble CD40 Ligand Levels in Children with Newly Diagnosed Graves’ Disease.
    Metwalley KA; Farghaly HS; Raafat DM; Ismail AM; Saied GM
    J Clin Res Pediatr Endocrinol; 2020 Jun; 12(2):197-201. PubMed ID: 31782290
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Circadian and pulsatile TSH secretion under physiological and pathophysiological conditions.
    Brabant G; Prank K; Ranft U; Bergmann P; Schuermeyer T; Hesch RD; von zur Mühlen A
    Horm Metab Res Suppl; 1990; 23():12-7. PubMed ID: 2210627
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Predictive value of TSH receptor antibody measurement in Graves' disease is independent on the TSH receptor (human or porcine) but depends on the generation of the assay used.
    Zöphel K; Wunderlich G
    Endocr J; 2006 Dec; 53(6):869-70. PubMed ID: 17001107
    [No Abstract]   [Full Text] [Related]  

  • 79. [TSH receptor autoantibody: its historical background and interpretation of the data on TSAb, TSBAb and TBII].
    Saito J; Tatsuno I; Iwamoto I
    Nihon Rinsho; 1999 Aug; 57(8):1829-33. PubMed ID: 10483260
    [No Abstract]   [Full Text] [Related]  

  • 80. Thyroid stimulating antibodies in rheumatoid arthritis: an in vitro phenomenon.
    Kirkegaard C; Bech K; Bliddal H; Danneskiold-Samsoe B; Feldt-Rasmussen U
    J Endocrinol Invest; 1987 Oct; 10(5):495-8. PubMed ID: 2892878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.